Kobayashi Nobuo, Numaguchi Yuji, Fuwa Sokun, Uemura Akihiro, Matsusako Masaki, Okajima Yuka, Ishiyama Mitsutomi, Takahashi Osamu
Department of Radiology, St Luke's International Hospital, Tokyo, Japan.
Acad Radiol. 2009 Feb;16(2):136-43. doi: 10.1016/j.acra.2008.05.005.
We investigated the efficacy of prophylactic cement injection into the vertebral body adjacent to fractured vertebra to prevent new fractures after percutaneous vertebroplasty (PV).
Between February 2002 to August 2004, PV was performed for osteoporotic compression fractures in 89 consecutive patients. All patients underwent PV for only fractured vertebrae. Between September 2004 and October 2006, we performed prophylactic cement injection for 155 patients, with cement injected into the non-fractured vertebra adjacent to the fractured vertebra, immediately above the fractured vertebra in the same procedure. We evaluated the frequency of new vertebral fractures and the efficacy of prophylactic therapy.
In the non-prophylactic group, 15 of 89 patients (16.8%) developed new fractures within 3 months and 20 of 89 patients (22.4%) developed new painful compression fractures within a year after the first PV. These fractures occurred mostly in adjacent vertebra, particularly in the vertebra immediately superior to the treated one and occurred in the lower thoracic and upper lumbar spine. In the prophylactic group, 7 of 155 patients (4.5%) developed new compression fractures within 3 months and 15 of 155 patients (9.7%) developed new compression fractures within 1 year. Statistical analysis showed that fewer new fractures developed in the prophylactic group than in the non-prophylactic group at both 3 months (P = .0020, Fisher's exact test) and 1 year (P = .0079).
Prophylactic cement injection into non-fractured vertebrae adjacent to fractured vertebrae may prevent new compression fractures after vertebroplasty for osteoporotic patients.
我们研究了向骨折椎体相邻的椎体预防性注射骨水泥以预防经皮椎体成形术(PV)后新发骨折的疗效。
2002年2月至2004年8月期间,对89例连续的骨质疏松性压缩骨折患者进行了PV治疗。所有患者仅对骨折椎体进行了PV治疗。2004年9月至2006年10月期间,我们对155例患者进行了预防性骨水泥注射,在同一操作中,将骨水泥注入骨折椎体相邻的未骨折椎体,位于骨折椎体上方紧邻处。我们评估了新发椎体骨折的频率和预防性治疗的疗效。
在非预防性治疗组中,89例患者中有15例(16.8%)在首次PV后3个月内发生新发骨折,89例患者中有20例(22.4%)在1年内发生新的疼痛性压缩骨折。这些骨折大多发生在相邻椎体,尤其是紧邻治疗椎体上方的椎体,且发生在下胸椎和上腰椎。在预防性治疗组中,155例患者中有7例(4.5%)在3个月内发生新的压缩骨折,155例患者中有15例(9.7%)在1年内发生新的压缩骨折。统计分析表明,预防性治疗组在3个月时(P = 0.0020,Fisher精确检验)和1年时(P = 0.0079)发生的新发骨折均少于非预防性治疗组。
向骨折椎体相邻的未骨折椎体预防性注射骨水泥可能预防骨质疏松患者椎体成形术后新的压缩骨折。